Unity Biotechnology, Inc.UBXNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank63
3Y CAGR+22.7%
5Y CAGR-0.6%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+22.7%/yr
vs +21.4%/yr prior
5Y CAGR
-0.6%/yr
Recent acceleration
Acceleration
+1.4pp
Accelerating
Percentile
P63
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 2.53 | +152.0% |
| 2023 | 1.00 | +116.5% |
| 2022 | 0.46 | -66.1% |
| 2021 | 1.37 | -57.5% |
| 2020 | 3.22 | +23.4% |
| 2019 | 2.61 | -8.9% |
| 2018 | 2.86 | +354.0% |
| 2017 | 0.63 | +145.7% |
| 2016 | -1.38 | - |